Nav: Home

AI-guided robotics enable automation of complex synthetic biological molecules

September 17, 2019

CAMBRIDGE, Mass., September 17, 2019 - A cross-disciplinary team of MIT researchers have published details of an artificial intelligence (AI) guided robotic platform for flow synthesis of small molecule organic compounds. The paper appeared in the August 9, 2019 issue of Science.

While small organic molecules are essential for many disciplines including drug discovery, the identification and development of synthetic routes creates a bottleneck due to the need for time-consuming manual tasks and lengthy design-synthesize-test iterations. Despite the availability of laboratory automation, experimental synthesis platforms still require manual configuration by expert chemists.

In this publication, the authors describe the development and use of a platform that combines artificial intelligence-driven synthesis planning, flow chemistry and a robotically controlled experimental platform to minimize the need for human intervention in the synthesis process from ideation through to manufacturing. Synthetic routes are proposed through generalization of millions of published chemical reactions and validated in silico to maximize the likelihood of success. Additional implementation details are determined by expert chemists and recorded in recipe files, which are executed by a modular continuous-flow platform that is automatically reconfigured by a robotic arm to set up the required unit operations and carry out the reaction.

"One of the major challenges in automating small molecule synthesis is the diversity of organic reactions and the difficulty in finding compatible reaction conditions to support multistep synthesis. Additionally, creating a system capable of supporting the range of reaction conditions in terms of temperatures, pressures and chemical compatibilities poses a serious engineering challenge," said Justin Lummiss, PhD, a co-first author on the Science publication who conducted research as a Postdoctoral Fellow at MIT.

Lummiss and Dale Thomas, PhD (another co-first author of the Science paper) are leveraging an AI-guided approach to address similar, longstanding challenges with custom peptide synthesis and purification at Mytide Therapeutics. Mytide is using AI to enable end-to-end peptide manufacturing in a truly autonomous fashion, including optimized reaction planning, real-time process optimization for in-sequence process modifications and robotics.

"Similar challenges exist in the automation of small molecule and peptide synthesis," noted Dr. Lummiss, who is now a Senior Scientist at Mytide. "We have made important strides in addressing significant engineering obstacles for small molecules and are now focused on new challenges with peptide synthesis and manufacturing".

Thomas and Lummiss' current work at Mytide Therapeutics focuses on the development of an integrated platform for peptide manufacturing and discovery of novel peptide therapeutics. The AI-guided, automated platform is designed to address challenges not only in synthesis but also in purification of custom peptides.

"The fully automated platform we are developing at Mytide simplifies the challenges of peptide synthesis through mastery of a single reaction - amide bond formation," noted Dr. Thomas, a Co-Founder of Mytide. "By reducing the synthetic diversity of conventional approaches to peptide synthesis, we have been able to address longstanding challenges in synthesis and purification, as well as reducing barriers of purity bottlenecks that presently limit current large-scale peptide manufacturing for drug products".

Thomas and Lummiss are excited about the future applications of their current work at Mytide and its ability to have a meaningful impact. Their advances in AI-guided automation and technology are driving Mytide's ultimate goal of accelerating the discovery and development of peptide therapeutics targeting a wide range of diseases, including cancer therapy, infectious disease, and inflammatory disorders.
-end-
About Mytide Therapeutics

Mytide Therapeutics' multi-disciplinary team of engineers, biochemists and computer scientists has created the first company to take a technologically advanced approach to solving long-standing challenges in both peptide synthesis and purification. Mytide's fully automated peptide manufacturing technology, coupled with predictive analytics and machine learning, is challenging decades-old paradigms to enable cost-efficient research and development, therapeutic manufacturing and therapeutic discovery. Our aim is to accelerate the discovery and development of life-saving peptide therapeutics for serious conditions ranging from metabolic conditions to oncology to inflammatory disorders to infectious diseases.

The Yates Network

Related Synthesis Articles:

New technology enables fast protein synthesis
MIT chemists have developed a protocol to rapidly produce protein chains up to 164 amino acids long.
Green chemistry approaches to the synthesis of coumarin derivatives
Coumarin derivatives (coumarins) are a class of compounds with a wide range of biological activities, which have found their application in medicine, pharmacology, cosmetics and food industry.
Synthesis against the clock
Radiolabeled molecules help nuclear physicians to detect and precisely target tumors, which are often developing due to pathological changes in metabolic processes.
Ammonia synthesis made easy with 2D catalyst
Rice University researchers use their knowledge of 2D nanomaterials and develop a 'green' method for the small-scale synthesis of ammonia.
New synthesis method yields degradable polymers
MIT chemists have come up with a way to make certain drug-delivery polymers more readily degradable by adding a novel type of building block to the polymer backbone.
A new strategy for the synthesis of complex natural products
Chemists from the University of Basel have succeeded in synthesizing two complex natural products from the group of dithiodiketopiperazines (DTPs).
A new, unified pathway for prebiotic RNA synthesis
Adding to support for the RNA world hypothesis, Sidney Becker and colleagues have presented what's not been shown before -- a single chemical pathway that could generate both the purine and pyrimidine nucleosides, the key building blocks of RNA.
Bottom-up synthesis of crystalline 2D polymers
Scientists at TU Dresden and Ulm University have succeeded in synthesizing sheet-like 2D polymers by a bottom-up process for the first time.
Clarification of a new synthesis mechanism of semiconductor atomic sheet
Researchers at Tohoku University in Japan succeeded in clarifying a new synthesis mechanism regarding transition metal dichalcogenides (TMD), which are semiconductor atomic sheets having thickness in atomic order.
Synthesis of UV absorbers from cashew nut shell liquid
Researchers succeeded in using cashew nut shell liquid (CNSL) as a substitute for petroleum in organic synthesis.
More Synthesis News and Synthesis Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Making Amends
What makes a true apology? What does it mean to make amends for past mistakes? This hour, TED speakers explore how repairing the wrongs of the past is the first step toward healing for the future. Guests include historian and preservationist Brent Leggs, law professor Martha Minow, librarian Dawn Wacek, and playwright V (formerly Eve Ensler).
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.